Share

Big pharma companies vie for hemophilia gene therapy breakthrough

CNBC's Meg Tirrell explains why major pharmaceutical companies are competing to come up with successful gene therapy treatments for hemophilia.
01:17
Fri, Nov 16 20187:08 AM EST